**China’s envoy urges India to understand dragon‑elephant tangle post‑Modi‑Xi summit**

*Beijing,‑elephanttanglepost‑Modi‑ 3 November 2025* – In a rare public address following the latest Modi‑Xi summit, China’s ambassador to New Delhi, Li Wei, called on Indian policymakers to grasp the complexities of the “dragon‑elephant” relationship before any further steps are taken on trade, security or regional cooperation. The envoy’s remarks come amid a backdrop of fluctuating bilateral ties, marked by both high‑level dialogue and persistent border frictions.

### Key Developments
The summit, held in New Delhi on 28 October, yielded a joint statement emphasizing the resumption of direct flights, the revival of the China‑India Business Forum, and a pledge to restart negotiations on the long‑standing trade imbalance. However, behind the diplomatic niceties, both sides acknowledged that the Line of Actual Control (LAC) remains a flashpoint, with recent troop build‑ups in Ladakh and Arunachal Pradesh prompting renewed calls for confidence‑building measures.

Ambassador Li highlighted three immediate priorities: (1) finalising a framework for mutual troop disengagement, (2) expanding market access for Indian pharmaceuticals and IT services in China, and (3) establishing a joint working group on supply‑chain resilience for critical minerals. He warned that without a clear understanding of the intertwined economic and security strands—what he metaphorically termed the “dragon‑elephant tangle”—any progress would be fragile.

### Industry Analysis
Analysts note that the dragon‑elephant metaphor captures the asymmetry of the relationship: China’s manufacturing behemoth versus India’s growing services and digital sectors. Trade data from 2024 shows a $101 billion deficit in India’s favour, driven largely by imports of electronics, machinery and steel. Conversely, Indian services exports—particularly in software and healthcare—have risen 12 % year‑on‑year, presenting a niche where China seeks greater involvement.

The ambassador’s push for pharmaceutical market access aligns with India’s ambition to become a global hub for generic drugs, a sector where Chinese demand is projected to grow by 8 % annually through 2030. At the same time, India’s cautious stance on Chinese investment in critical infrastructure reflects broader geopolitical concerns, especially after the 2023

(责任编辑：Trending Topics)